Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD5 Mouse, Clone: CRIS-1, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2328250.02MG
Description
CD5 Monoclonal specifically detects CD5 in Human, Rhesus Macaque samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Functional.Specifications
CD5 | |
Monoclonal | |
Unconjugated | |
PBS with 0.05% BSA. with 0.05% Sodium Azide | |
CD5 antigen, CD5 antigen (p56-62), CD5 molecule, LEU1T-cell surface glycoprotein CD5, Lymphocyte antigen T1/Leu-1, T1 | |
Mouse | |
67 kDa | |
0.02 mg | |
Adaptive Immunity, Cell Biology, Cytokine Research, Immunology, Phospho Specific | |
921 | |
Human, Primate | |
Purified |
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Frozen) | |
CRIS-1 | |
Flow Cytometry 0.5-1ug/million cells, Immunocytochemistry/Immunofluorescence 0.5-1ug/ml, Immunoprecipitation 0.5-1ug/500ug protein lysate, Immunohistochemistry-Frozen 0.5-1.0ug/ml, SDS-Page | |
P06127 | |
CD5 | |
Stimulated human leukocytes | |
Protein A purified | |
RUO | |
Primary | |
Recognizes a 67kDa transmembrane protein, which is identified as CD5 (HLDA I; WS Code T 29HLDA III; WS Code T 530). The CD5 antigen is found on 95% of thymocytes and 72% of peripheral blood lymphocytes. In lymph nodes, the main reactivity is observed in T cell areas. Anti-CD5 is a pan T-cell marker that also reacts with a range of neoplastic B-cells, e.g. chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, and a subset (∼10%) of diffuse large B-cell lymphoma. CD5 aberrant expression is useful in making a diagnosis of mature T-cell neoplasms. | |
Store at 4C. | |
IgG2a κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction